Vorsitz: H. Ehmke (Hamburg), U. Landmesser (Berlin)
| 14:30 | (V1437) | The DZHK funding scheme for translational projects |
| H. Ehmke (Hamburg) | ||
| 14:40 | (V1438) | First anti-miR therapy for cardiovascular disease |
| S. Dimmeler (Frankfurt am Main) | ||
| 14:55 | Discussion | |
| 15:00 | (V1439) | Inflammation as new therapeutic target for atherosclerosis: CD40-TRAF6 inhibition |
| C. Weber (München) | ||
| 15:15 | Discussion | |
| 15:20 | (V1440) | Generation and functional characterization of macrophage cell lines from yolk sac precursors |
| C. Schulz (München) | ||
| 15:35 | Discussion | |
| 15:40 | (V1441) | Novel inotropic/lusitropic biologics against acute decompensated heart failure |
| P. Most (Heidelberg) | ||
| 15:55 | Discussion |
| 16:00 - 17:30 | Pause - Posterdiskussion |